⌘K

Home/Filings/4/0000810084-08-000039

4//SEC Filing

CHASE RANDAL D 4

Accession 0000810084-08-000039

CIK 0000810084other

View on SEC.gov Company Profile

Filed

Dec 8, 7:00 PM ET

Accepted

Dec 9, 8:40 PM ET

Size

7.4 KB

Accession

0000810084-08-000039

Insider Transaction Report

Form 4

Period: 2008-12-05

BIOJECT MEDICAL TECHNOLOGIES INCBJCT

Director

Transactions

Exercise/Conversion
BJCT Common Stock
2008-12-05+19,000→ 73,500 total
Exercise/Conversion
Restricted Stock Unit
2008-12-05−19,000→ 19,000 total
From: 2008-12-05→ BJCT Common Stock (19,000 underlying)

Footnotes (3)

[F1]50% Vesting per June 5, 2008 Board Grant.
[F2]Each Restricted Stock Unit represents a contingent right to receive one share of BJCT Common Stock.
[F3]No expiration date.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

BIOJECT MEDICAL TECHNOLOGIES INC

CIK 0000810084

Entity typeother

Related Parties

1

filerCIK 0001078784

Filing Metadata

Form type: 4
Filed: Dec 8, 7:00 PM ET
Accepted: Dec 9, 8:40 PM ET
Size: 7.4 KB

View on SEC.gov